Krishna Pada Bhabak

21PUBLICATIONS
23CO-AUTHORS
Molecular targetsCancer cell biologyNatural products and bioactive compoundsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 02, 2026
Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity.

|May 27, 2026
Stimuli-responsive fluorogenic prodrugs of potent inhibitors targeting overexpressed metabolic enzymes in cancer.

|Dec 04, 2025
Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways.

Nikita Pal, Rahul Kesarwani, Tapas K Mandal

|Aug 04, 2025
Nitro-Substituted Benzylic Organochalcogenides as Anticancer Agents: Unravelling the Multifaceted Pathways to Combat Triple-Negative Breast Cancer.

Pallavi Barman, Ratul Chakraborty, Roopjyoti Misra

|Feb 28, 2025
Synthetic organic polysulfanes as H2S donors and anticancer agents.

Abu Sufian, Debojit Bhattacherjee, Pallavi Barman

|Dec 04, 2024
Synthesis of Thiazolidinedione- and Triazole-Linked Organoselenocyanates and Evaluation of Anticancer Activities Against Breast Cancer with Mechanistic Investigations.

Nikita Pal, Kaustav Banerjee, Shilpi Sarkar

Pageof 4

Frequent Collaborators

8 joint publications

Pallavi Barman

4 joint publications

Debojit Bhattacherjee

4 joint publications

Md Badirujjaman

4 joint publications

Rahul Kesarwani